Furthermore, it is apparently felt by a group of these commentators that major efforts are required to be certain that this 'misconception' is dispelled before a cancer patient is permitted to enter a phase 1 oncology trial.
8 Currently, in the preclinical stage, there is a 30-valent vaccine (reformulated from a 26-valent vaccine) based on the variable N-terminal regions of the surface M protein of GAS. 9 Furthermore, another vaccine (J8 vaccine), based on antigens from the conserved C-repeat portion of the M-protein, has recently entered a phase 1 trial.
Although, to date, there is not a single 'positive hit' published from a zebrafish-based drug screen for neurological disorders that has entered a Phase 1 clinical trial, the protective compounds discovered in the recent studies described above are very promising leads for future investigation.
Because of this early promise, PLX4032 entered a Phase 3 trial directly after Phase 1.
Originally developed to treat cancer, saracatinib was recently shown to restore brain function in mouse models of Alzheimer's disease and entered a Phase 2a clinical trial within 18 months — a process that would take up to a decade using an untested compound.
But the Thai molecular epidemiology has been gradually growing in complexity and now it seems to be entering a new phase [3], [9].
The antigens were the Plasmodium yoelii MSP1-19 antigen (C-terminal 19-kDa processing fragment of MSP1) which is already in clinical trials with different adjuvants [17], [18], the Ag85B-ESAT-6 fusion antigen of Mycobacterium tuberculosis which recently went through a phase Ia trial and now has entered a phase Ib trial [19] and the well-established chlamydia vaccine antigen MOMP [20], [21].
A modified vaccinia Ankara viral vaccine (MVAAg85A) is the only candidate vaccine that has completed several phase I clinical studies and entered a phase II trial [29].
Patients who completed these trials were eligible to enter a phase III open-label 1-year extension study [ 25].
Wild type embryos at this developmental stage stop to proliferate after M16 by entering a G1/0 phase (Knoblich et al., 1994 ). 2xHis-GU embryos apparently also enter a G1/0 phase, enforced by the ongoing developmental program.
